COLLEEN CLINE: Open Payments
NPI 1568748986 · SHREVEPORT, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,741 in 93 payments from 22 companies in 2025. Trend: 2023 $1,897 · 2024 $1,647 · 2025 $1,741
Food & beverage: $1,741
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 33 | $484 |
| PFIZER INC. | 15 | $253 |
| Inspire Medical Systems, Inc. | 2 | $184 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $101 |
| Novo Nordisk Inc | 5 | $92 |
| Lilly USA, LLC | 5 | $85 |
| AstraZeneca Pharmaceuticals LP | 5 | $83 |
| Vanda Pharmaceuticals Inc. | 3 | $67 |
| Amgen Inc. | 3 | $50 |
| Corcept Therapeutics | 2 | $47 |
Products named: VRAYLAR, QULIPTA, INSPIRE, NURTEC ODT, UBRELVY, Kerendia, AIRSUPRA, ELIQUIS.
Industry payments across LA — which companies pay providers there.
